Dare Bioscience Inc. (NASDAQ: DARE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT DARE BIOSCIENCE INC.

Dare Bioscience Inc. (NASDAQ: DARE)
Listen to this Section


$1.91
-0.2750 ( -12.60% ) 331.8K

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Clinical Trial Pipeline Stages


Drug Name Stage
XACIATO (DARE-BV1)DetailsBacterial infection Approved
Ovaprene®DetailsContraceptive Phase 3
Sildenafil Cream, 3.6%DetailsSexual desire disorder, Sexual dysfunction Phase 3
DARE-VVA1 (Tamoxifen formulation)DetailsVulvovaginal Candidiasis Phase 2
DARE-PDM1DetailsPrimary dysmenorrhea Phase 1
DARE-PTB1DetailsPreterm birth Phase 1

Market Data


Open $1.91
Previous Close $2.18
Volume 331.8K
Market Cap $30.71M
Day Range $1.90 - $2.19
52 Week Range $1.27 - $9.19
Shares Outstanding 14.98M
Change % -12.60%
Net Change ▼ -0.2750
Insider Ownership -0.15%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2014
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,530,000.00

Date Type Amount Purchased Purchaser
2024-06-07 Sale -40000.00 Matz Gregory W
2024-06-07 Sale -40000.00 Kelley Susan L.
2024-06-07 Sale -40000.00 RASTETTER WILLIAM H
2024-06-07 Sale -40000.00 Steele Robin Joan
2024-06-07 Sale -40000.00 Grossman Jessica D.
2024-03-14 Sale -290000.00 Haring-Layton MarDee
2024-03-14 Sale -750000.00 JOHNSON SABRINA MARTUCCI
2024-03-14 Sale -290000.00 Fair John A

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 13, 2025
10-q Quarterly Reports 89 Nov 13, 2025
4 Insider transactions 1 Sep 04, 2025
8-k 8K-related 62 Sep 02, 2025
10-q Quarterly Reports 66 Aug 14, 2025
8-k 8K-related 14 Aug 14, 2025
8-k 8K-related 12 Jul 25, 2025
8-k 8K-related 12 Jul 21, 2025
8-k 8K-related 14 Jul 14, 2025
4 Insider transactions 1 Jul 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy